An insight from Stavros Nicolaou into Aspen’s outreach efforts over FY 2022 in the Eastern Cape, South Africa,
An insight from Stavros Nicolaou into Aspen’s outreach efforts over FY 2022 in the Eastern Cape, South Africa,
Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical company, has been presented with the South African Government and Department of International Relations and Cooperations’ (“DIRCO”) Ubuntu Award in the Economic Diplomacy (Global) category at its prestigious 6th annual awards ceremony hosted in Cape Town for this purpose. This… Continue reading Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award
Durban, South Africa – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to confirm that one of its wholly-owned South African subsidiaries, Aspen SA Operations (Pty) Limited (“Aspen SA”), has confirmed a non-binding term sheet with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen… Continue reading Aspen confirms non-binding term sheet on manufacture and sale of an Aspen- branded COVID-19 vaccine throughout Africa
Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today welcomed Kenyan President, His Excellency President Uhuru Kenyatta, to its world class flagship manufacturing site in Gqeberha. President Kenyatta’s visit to Aspen forms part of a broader collaboration and deepening of ties between South Africa and Kenya to lessen Africa’s dependence on… Continue reading Aspen welcomes Kenyan President Uhuru Kenyatta to its Gqeberha manufacturing site
Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted the Honorable Minister of Trade, Industry and Competition, Mr Ebrahim Patel who officially opened Aspen’s world class general anaesthetics production line at its Gqeberha-based flagship manufacturing site. This manufacturing capability will convert Aspen’s Gqeberha facility into one of the largest manufacturing… Continue reading Minister Ebrahim Patel opens Aspen’s world class general anaesthetic manufacturing line
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report the following salient financial results for the year ended 30 June 2021: *The prior year comparatives for continuing operations have been restated to include the discontinued European business within discontinued operations in compliance with IFRS… Continue reading Aspen increases revenue from continuing operations by 12% to R37,8 billion
Aspen confirmed on 26 July 2021 that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, were being released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site. These vaccines will be further distributed throughout South Africa in line with the various… Continue reading Stephen Saad discusses the J&J vaccine release with eNCA’s Sally Burdett
Durban, South Africa – Aspen, a global multinational specialty pharmaceutical company, is pleased to confirm that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, will be released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site later today. These vaccines will… Continue reading Aspen confirms release of Covid-19 vaccines to Johnson & Johnson for supply to South Africa
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.
